Loading insider details...
Beta
Latest Form 4 (Jun 27, 2025): Grant/Award of 21,950 SNTI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 27, 2025 | Senti Biosciences, Inc. (SNTI) | Grant/Award | 21,950 | n/a |
| Mar 11, 2025 | Senti Biosciences, Inc. (SNTI) | Grant/Award | 43,900 | n/a |
| Jul 12, 2024 | Senti Biosciences, Inc. (SNTI) | Grant/Award | 62,500 | n/a |
| Jun 18, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Jun 29, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Jun 21, 2023 | Senti Biosciences, Inc. (SNTI) | Grant/Award | 62,500 | n/a |
| Jul 15, 2022 | Senti Biosciences, Inc. (SNTI) | Grant/Award | 125,000 | n/a |
| Jun 29, 2022 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 19,000 | n/a |
| Jun 11, 2021 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 15,000 | n/a |
| Jun 15, 2020 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 9,285 | n/a |